08:00 -08:30
Registration

08:30 – 12:15

Plenary session I

Chair: Britta Wahren (Sweden)

Themes

1. Building capacity in scientific skills and leadership in Africa: Strategies and experiences
2. Networking within the partnership

Opening

08:30  Diana Dunstan, EEIG-EDCTP Chair
Welcoming address and an update since the Second Forum

09:00  Pascoal Mocumbi, HR
European and African Partnership: Challenges and Opportunities

09:30  Lennarth Hjelmaker, HIV/AIDS Ambassador, Sweden
Official opening address:

10:00 TEA

Key-note addresses

Chair: Britta Wahren (Sweden) and Charles Mgone (ES)

10:30  Hannah Akuffo/Berit Olsson (Sweden)
Research capacity building in Africa: Learning from the SIDA/SAREC experience

11:00  Eric Buch (NEPAD)
NEPAD strategies for developing regional capability in combating diseases of poverty in Africa

11:30  Diana Dunstan (UK)
North-North Networking: EDCTP as a vehicle for European member state collaboration and implications for partnership with Africa

12:00  General discussion

12:15  LUNCH and electronic poster viewing

14:00 – 17:00

Round Table I
Partnership and Networking

14:00 Introductory presentations and facilitated discussion

16:00 TEA 

16:30 – 17:00  Rapporteur’s provisional report (Plenary)

1. Developing multicentre clinical trial partnerships at country level - involving disease control programmes, communities and other stakeholders in clinical trials in Africa
2. North-North Networking – is integration of national programmes achievable and why is it important?
3. North-South Partnerships and co-funding/supplementary grants on EDCTP projects – why, how, whose responsibility?

Room A:  North-North Networking, Co-funding and supplementary grants in North-South Partnerships

Facilitator/Rapporteur: Stefan Wagener (Germany), Olle Stendahl (Sweden), Judith de Kroon (Netherlands), Getachew Aderaye (Ethiopia)

• Bruno Gryseels (Belgium)
  

• Abdoulaye Djimde (Mali)

08:00 – 12:15

Plenary session II

Theme

1. Making clinical trials run cost-effectively and without unnecessary constraints: Harmonising regulatory and ethics requirements, ensuring efficient trial/project management, networking, sharing infrastructure and knowledge, sustaining clinical research capacity, centralising/standardising quality assurance and laboratory support

Chairs: Simon Agwale (Nigeria) and Laura Brum (Portugal)

08:00  Andrew Kitua (Tanzania)
South-South Networking: Need for Nodes of Excellence

08:30  Precious Matsoso (WHO)
Harmonising drug regulation in Africa

09:00  Leen Rigouts (Belgium)
Supra-national laboratories for quality-assurance and training

09:30  Jelle Thole (Netherlands)
Managing networks: Lessons for multicentre clinical projects

10:00 TEA

10:30  Lahouari Bergharbi (WHO Geneva)
Regulatory challenges to clinical trials of vaccines in Africa

11:00  Kalifa Bojang (Gambia)       
Experiences in the conduct of clinical trials

11:30  Tumani Corrah (Gambia)
Sustaining trial capability: Strategies for building and retaining skills

12:00  General discussion

12:15  LUNCH and electronic poster viewing

14:00 – 17:00

Round Table II
Capacity building and Scientific Leadership Development

14:00 Introductory presentations and facilitated discussion

16:00 TEA 

16:30 – 17:00  Rapporteur’s provisional report (Plenary)

1. Sustainable institutional capability and human resource capacity building for clinical research and laboratory support in Africa – what will it take to successfully achieve this goal?
2. Defining the necessary framework for career development and effective utilisation of existing skills in clinical and laboratory research in Africa
3. Scientific Leadership Development in Africa – is an integrated effort from international cooperative programmes called for?

Room A:  Capacity building for clinical trials in Africa
Facilitator/Rapporteur: Lynn Zijenah (Zimbabwe), Michael Makanga (ES)

• Peter Ndumbe (Cameroon)
• Kalifa Bojang (Gambia)
  

• Ogabora Doumbo (Mali)
   

Room C:  Framework for career development in clinical trials
Facilitator/Rapporteur: Aissatou Toure (Senegal), Thomas Nyirenda (ES)

• Steven Wayling (WHO/Geneva)
   

08:00 – 12:00

Plenary session III

Themes

• Partnership and African Leadership for conducting clinical trials
• Experiences from the field and reports from EDCTP projects

Chairs: Richard Adegbola (Gambia/Nigeria) and Peter Kremsner (Austria)

Key-note addresses

08:30  Joseph Odhiambo (Tanzania)
Partnership and African leadership in Tuberculosis drug and vaccine research

09:00  Sodiomon Sirima (Burkina Faso)
Partnership and African leadership in Malaria drug and vaccine research

09:30  Souleymane Mboup (Senegal)
Partnership and African leadership in HIV/AIDS drug and vaccine research

10:00  Diarmuid McClean
Partnership and African leadership from funders’ perspective

10:30 TEA

Reports from the First EDCTP Investigators’ Meeting

11:00  Abraham Alabi
Viral load dynamics as an insight to the therapeutic vaccine efficacy in HIV dual infections

11:20  Muhammed Bakari
The HIVIS project - A North-Shouth collaborative study of safety and immunogenicity of multigene, multiclade HIV-1 plasmid DNA prime and MVA boost

11:40  Paul van Helden
Surrogate markers to predict the outcome of antituberculosis therapy

12:00  Maowia Mukhtar
Epidemiological patterns of pulmonary tuberculosis in easter Sudan

12:20  General discussion

12:30  LUNCH and electronic poster viewing

14:15 – 16:15

Plenary session IV
Summary and recommendations from Round Table discussions

Chairs: Bernard Fourie (South Africa) and Patrice Debre (France)

14:15  Charles Mgone (ES)
EDCTP priorities for capacity building, training, and networking

14:30  Rapporteurs’ reports from Round Table I – Partnership and Networking

• North-North networking
• Multicentre partnerships for clinical trials in Africa
• Co-funding and supplementary grants in North-South Partnerships

15:00  Rapporteurs’ reports from Round Table II - Capacity Building and Scientific Leadership Development

• Capacity building for clinical trials in Africa
• Scientific leadership development in Africa
• Framework for career development in clinical trials

15:30  General discussion and concluding recommendations
16:00  Pascoal Mocumbi, Haut Représentant, EDCTP

Concluding remarks

16:15 Closing